DUBLIN, April 6, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Prevention and Treatment of Prostate Cancer: Technologies and Global Markets" report to their offering.
The report includes an overview of the market for the prevention and treatment of prostate cancer, with coverage of the mechanisms of disease development, detection and diagnosis, and anticancer agents. It provides analyses of global market trends, with data from 2012, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
It contains discussion of risk factors, natural history, epidemiology, and the genetics of prostate cancer. As well as examinations of prostate-specific antigen (PSA) screening, including the causes of PSA changes, PSA thresholds, and controversies over the screening.
It provides coverage of emerging therapies, including combination therapy, therapeutic vaccines, inhibitors of kinase signaling pathways, proteasome inhibitors, angiogenesis inhibitors, and immunotherapeutic agents.
The scope of this study is testing, screening technology and also therapeutics markets for prostate cancer. The report also includes the regulatory environment, current technologies, new technologies, prostate cancer incidence, market projections and market share, along with latest trends and new developments.
Screening for diagnosis, therapy via drug, surgery or radiation is measured and broken down by PSA testing, digital rectal exam (DRE), prostate biopsy, hormone therapy, chemotherapy, immunotherapy, external beam radiation therapy (EBRT), prostatectomy and brachytherapy.
- Abbott Laboratories
- Active Biotech AB
- Bavarian Nordic A/S
- Bayer HealthCare Pharmaceuticals
- Bristol-Myers Squibb
- C.R. Bard
Key Topics Covered:
2: Summary and Highlights
4: Prostate Cancer Information
5: Prostate Cancer Screening and Diagnosis
6: Prostate Cancer: Therapeutic Interventions
7: Prostate Cancer Therapeutics in the Global Market
8: Global Burden of Cancer
9: Prostate Cancer and Diagnostic Market
10: Prostate Cancer Treatment Market
11: Prostate Cancer Drugs Market
12: Emerging Prostate Cancer Drugs
13: Prostate Cancer Patents
14: Selected Company Profiles
15: References and End Notes
For more information about this report visit http://www.researchandmarkets.com/research/l88pst/prevention_and
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/prevention-and-treatment-of-prostate-cancer---expected-to-reach-651-billion---coverage-of-mechanisms-of-disease-development-detection-diagnosis--anticancer-agents---research-and-markets-300435865.html
SOURCE Research and Markets